Literature DB >> 19169754

Nanoneoadjuvant therapy of gastrointestinal stromal tumor (GIST).

Ronald P DeMatteo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19169754     DOI： 10.1245/s10434-009-0316-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  6 in total

Review 1.  Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?

Authors:  Margaret von Mehren; Nicolas Widmer
Journal:  Cancer Treat Rev       Date:  2010-11-24       Impact factor: 12.111

Review 2.  Management of gastric polyps: an endoscopy-based approach.

Authors:  Yasser H Shaib; Massimo Rugge; David Y Graham; Robert M Genta
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

3.  c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.

Authors:  S S Ganguly; L S Fiore; J T Sims; J W Friend; D Srinivasan; M A Thacker; M L Cibull; C Wang; M Novak; D M Kaetzel; R Plattner
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

4.  Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Authors:  Zannel Blanchard; Nicole Mullins; Pavani Ellipeddi; Janice M Lage; Shawn McKinney; Rana El-Etriby; Xu Zhang; Raphael Isokpehi; Brenda Hernandez; Wael M Elshamy
Journal:  PLoS One       Date:  2014-04-30       Impact factor: 3.240

5.  Gastrointestinal stromal tumor with multisegmental spinal metastases as first presentation: A case report and review of the literature.

Authors:  Yan Kong; Xiao-Wei Ma; Qian-Qian Zhang; Yi Zhao; He-Lin Feng
Journal:  World J Clin Cases       Date:  2021-02-26       Impact factor: 1.337

6.  Current management and prognostic features for gastrointestinal stromal tumor (GIST).

Authors:  Gurpreet Lamba; Ridhi Gupta; Byung Lee; Samir Ambrale; Delong Liu
Journal:  Exp Hematol Oncol       Date:  2012-06-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.